TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q4 2014. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,281,000 | +10.5% | 853,345 | -5.2% | 1.03% | -0.5% |
| Q2 2016 | $10,206,000 | -2.7% | 900,000 | 0.0% | 1.03% | +4.4% |
| Q1 2016 | $10,494,000 | +61.8% | 900,000 | +63.2% | 0.99% | +41.1% |
| Q4 2015 | $6,487,000 | +1.8% | 551,632 | -1.0% | 0.70% | +20.5% |
| Q3 2015 | $6,373,000 | -54.1% | 557,117 | -27.6% | 0.58% | -55.0% |
| Q2 2015 | $13,891,000 | +7.2% | 769,165 | +14.3% | 1.29% | -31.7% |
| Q1 2015 | $12,957,000 | +11.9% | 673,079 | +1.8% | 1.89% | +2.9% |
| Q4 2014 | $11,579,000 | +5.5% | 661,261 | +10.1% | 1.84% | +13.1% |
| Q3 2014 | $10,976,000 | -8.5% | 600,770 | +15.4% | 1.62% | +3.7% |
| Q2 2014 | $11,993,000 | +2.4% | 520,770 | +7.8% | 1.56% | +17.5% |
| Q1 2014 | $11,709,000 | -8.4% | 483,263 | -4.9% | 1.33% | -17.7% |
| Q4 2013 | $12,778,000 | +21.5% | 508,263 | +5.2% | 1.62% | +3.9% |
| Q3 2013 | $10,518,000 | +39.2% | 483,355 | +7.8% | 1.56% | +74.7% |
| Q2 2013 | $7,556,000 | – | 448,415 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |